JPWO2022071582A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022071582A5 JPWO2022071582A5 JP2022554148A JP2022554148A JPWO2022071582A5 JP WO2022071582 A5 JPWO2022071582 A5 JP WO2022071582A5 JP 2022554148 A JP2022554148 A JP 2022554148A JP 2022554148 A JP2022554148 A JP 2022554148A JP WO2022071582 A5 JPWO2022071582 A5 JP WO2022071582A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- group
- formula
- alkyl group
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020167928 | 2020-10-02 | ||
| PCT/JP2021/036449 WO2022071582A1 (ja) | 2020-10-02 | 2021-10-01 | 脂質ナノ粒子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022071582A1 JPWO2022071582A1 (https=) | 2022-04-07 |
| JPWO2022071582A5 true JPWO2022071582A5 (https=) | 2024-10-02 |
Family
ID=80951742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554148A Pending JPWO2022071582A1 (https=) | 2020-10-02 | 2021-10-01 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12458605B2 (https=) |
| EP (1) | EP4223314A4 (https=) |
| JP (1) | JPWO2022071582A1 (https=) |
| KR (1) | KR20230080451A (https=) |
| CN (2) | CN121698765A (https=) |
| AU (1) | AU2021355199A1 (https=) |
| CA (1) | CA3194148A1 (https=) |
| IL (1) | IL301837A (https=) |
| TW (1) | TW202228652A (https=) |
| WO (1) | WO2022071582A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025081791A (ja) * | 2022-03-31 | 2025-05-28 | 日東電工株式会社 | がん送達用医薬組成物または免疫賦活用組成物 |
| WO2023188830A1 (ja) * | 2022-03-31 | 2023-10-05 | 国立大学法人北海道大学 | 脂質ナノ粒子 |
| CN119585236A (zh) | 2022-07-19 | 2025-03-07 | 国立大学法人北海道大学 | 中性脂质及脂质纳米粒 |
| JPWO2024024156A1 (https=) * | 2022-07-29 | 2024-02-01 | ||
| JPWO2024071409A1 (https=) * | 2022-09-30 | 2024-04-04 | ||
| WO2025180480A1 (zh) * | 2024-03-01 | 2025-09-04 | 北京剂泰医药科技有限公司 | 靶向肌肉的脂质纳米颗粒 |
| TW202602853A (zh) * | 2024-03-21 | 2026-01-16 | 日商日東電工股份有限公司 | ｐＨ—敏感性陽離子脂質、包含其之脂質奈米顆粒及傳遞核酸之方法 |
| WO2026009946A1 (ja) * | 2024-07-04 | 2026-01-08 | 日東電工株式会社 | 非対称構造脂質 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0632008B1 (en) | 1993-06-01 | 1998-02-04 | Ono Pharmaceutical Co., Ltd. | Pentanoic acid derivatives |
| WO2007102481A1 (ja) | 2006-03-07 | 2007-09-13 | National University Corporation Hokkaido University | 目的物質の核内送達用ベクター |
| AU2012347605B2 (en) | 2011-12-07 | 2017-09-21 | Alnylam Pharmaceuticals, Inc. | Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents |
| US10182987B2 (en) * | 2014-05-20 | 2019-01-22 | National University Corporation Hokkaido University | Lipid membrane structure for intracellular delivery of siRNA |
| HUE053990T2 (hu) | 2015-07-22 | 2021-08-30 | Nitto Denko Corp | Nanorészecske liofilizált formák készítményei és eljárások |
| CN110520214B (zh) | 2017-04-13 | 2023-03-21 | 国立大学法人北海道大学 | 使用流路构造体的脂质粒子或微胞的形成方法 |
| KR102676927B1 (ko) * | 2017-06-15 | 2024-06-24 | 국립대학법인 홋가이도 다이가쿠 | siRNA 세포 내 송달을 위한 지질막 구조체 |
| JP2019151589A (ja) * | 2018-03-02 | 2019-09-12 | 国立大学法人北海道大学 | 脂質ナノ粒子 |
-
2021
- 2021-10-01 AU AU2021355199A patent/AU2021355199A1/en active Pending
- 2021-10-01 IL IL301837A patent/IL301837A/en unknown
- 2021-10-01 WO PCT/JP2021/036449 patent/WO2022071582A1/ja not_active Ceased
- 2021-10-01 CA CA3194148A patent/CA3194148A1/en active Pending
- 2021-10-01 US US18/247,612 patent/US12458605B2/en active Active
- 2021-10-01 CN CN202511824200.3A patent/CN121698765A/zh active Pending
- 2021-10-01 KR KR1020237014747A patent/KR20230080451A/ko active Pending
- 2021-10-01 TW TW110136757A patent/TW202228652A/zh unknown
- 2021-10-01 JP JP2022554148A patent/JPWO2022071582A1/ja active Pending
- 2021-10-01 EP EP21875878.7A patent/EP4223314A4/en active Pending
- 2021-10-01 CN CN202180067522.1A patent/CN116367718A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2022071582A5 (https=) | ||
| Gao et al. | Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction | |
| Forterre et al. | A comprehensive review of cancer MicroRNA therapeutic delivery strategies | |
| US20200000787A1 (en) | Medicament for treatment of liver cancer | |
| CN118234867A (zh) | 用于产生环状多核糖核苷酸的组合物和方法 | |
| DK3192870T3 (en) | CULTURED HEPATOCYTE FOR BLOOD CLEANING | |
| EP2543372A1 (en) | Medicament for the treatment of liver cancer | |
| JP2011518117A5 (https=) | ||
| EP3632425A1 (en) | Methods to mobilize progenitor/stem cells | |
| Kataoka et al. | Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis | |
| JP2012520082A5 (https=) | ||
| AU666372B2 (en) | Therapeutic compositions | |
| JP2009528346A5 (https=) | ||
| AU2002318927A1 (en) | Methods to mobilize progenitor/stem cells | |
| JP2011519346A (ja) | アレナウイルス感染症の治療のための抗ウイルス薬 | |
| CN104368004A (zh) | 一种用于运载抗肿瘤药物的核酸纳米结构及其制备方法和应用 | |
| EP2583691A1 (en) | Agent for treating renal fibrosis | |
| CN104540527A (zh) | Mir-15微小rna家族的抑制剂 | |
| Hsu et al. | MicroRNAs in liver health and disease | |
| EP2112931A1 (en) | Methods and compositions for transermal delivery of nucleotides | |
| EP4556000A1 (en) | Lyophilized composition of nucleic-acid-loaded lipid nanoparticles | |
| Firouzamandi et al. | Preparation, characterization, and in ovo vaccination of dextran-spermine nanoparticle DNA vaccine coexpressing the fusion and hemagglutinin genes against Newcastle disease | |
| US20250195642A1 (en) | Nucleic acid stabilizing solution for vaccines, therapy, diagnostics, storage, and transport | |
| Jiang et al. | The role of platelet-derived growth factor-B/platelet-derived growth factor receptor-β signaling in chronic atrial fibrillation | |
| US5925564A (en) | Expression vector systems and method of use |